← Back to Search

Peer Support for ADHD in Students (Summer STRIPES Trial)

N/A
Waitlist Available
Led By Margarret Sibley, Ph.D.
Research Sponsored by Seattle Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Meet Symptom and Impairment Criteria for DSM-5 ADHD
Be younger than 18 years old
Must not have
IQ < 70
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to end of 9th grade, an average of 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a program called summer STRIPES for ninth graders with ADHD. The program includes an orientation and regular support to help students transition to high school. It aims to boost motivation and important skills through training and engaging activities. The goal is to improve grades, attendance, and behavior.

Who is the study for?
This trial is for ninth grade students who meet the criteria for ADHD according to DSM-5, which includes having symptoms and related challenges. They must be attending a participating school. Students with an IQ below 70 or those placed in special education classes cannot participate.
What is being tested?
The study is testing 'Summer STRIPES', a peer-delivered intervention, against enhanced usual school services (SSU plus) for high school freshmen with ADHD. The effectiveness will be measured by GPA, attendance, disciplinary incidents, and ADHD symptoms based on parent and teacher reports.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there are no traditional side effects like you would expect from medication. However, participants may experience varying levels of stress or anxiety due to the nature of academic performance assessments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with ADHD according to DSM-5 criteria.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My IQ is below 70.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to end of 9th grade, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to end of 9th grade, an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Attention Deficit Hyperactivity Disorder Symptom Severity
Class Attendance
Grade Point Average
Other study objectives
Engagement and Fit Measures: Fidelity Checklists
Engagement and Fit Measures: Intervention Attendance
Engagement and Fit Measures: Intervention Credibility
+22 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Summer STRIPESExperimental Treatment1 Intervention
Up to two weeks of daily high school orientation (four hours per day) immediately prior to the start of ninth grade, staffed by peer interventionists (2:1 ratio + extra interventionist in case of absences) and a school staff member. Two sessions of summer parent training. During the school year, ninth grade students will continue to meet weekly with their peer interventionists in a group setting under the supervision of the school staff sponsor. School year follow-up component of summer STRIPES will occur for 16 weeks and will include weekly 30 minute meetings between peer and target students. Parent components during the school year will include optional monthly group problem solving sessions with the school staff sponsor and school mental health liaison and a weekly phone call (up to five minutes) from the school staff sponsor to discuss home contingency management.
Group II: Enhanced School Services as UsualActive Control1 Intervention
Students who are assigned to the SSU plus group will be referred to their identified school counselor for referral to services available in the school setting. The counselor will be provided with a report from the student's intake assessment that summarizes the student's symptoms and presenting problems. The student will also receive new school supplies at the beginning of ninth grade. In our past trials, SSU plus students typically received subject-specific tutoring or after-school homework help. We will systematically track services received by students in the SSU plus condition.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for ADHD include stimulant medications like methylphenidate, which work by increasing dopamine and norepinephrine levels in the brain to enhance focus and attention. Non-pharmacological treatments, such as structured activities and peer support programs like the summer STRIPES, aim to improve organizational skills, reduce distractions, and provide social support. These approaches help manage ADHD symptoms by addressing both neurological and behavioral aspects, leading to better overall symptom management and improved daily functioning for patients.
Managing Sleep in Adults with ADHD: From Science to Pragmatic Approaches.Sleep in Individuals with ADHD: Prevalence, Impacts, Causes, and Treatments.Methylphenidate and hospitalized adolescents with conduct disorder: Dose effects on classroom behavior, academic performance, and impulsivity.

Find a Location

Who is running the clinical trial?

University of WashingtonOTHER
1,804 Previous Clinical Trials
1,909,068 Total Patients Enrolled
2 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
1,194 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
National Institute of Mental Health (NIMH)NIH
2,881 Previous Clinical Trials
2,798,802 Total Patients Enrolled
95 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
19,998 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Seattle Children's HospitalLead Sponsor
310 Previous Clinical Trials
5,230,691 Total Patients Enrolled
12 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
1,667 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)

Media Library

Summer STRIPES Clinical Trial Eligibility Overview. Trial Name: NCT04571320 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Research Study Groups: Summer STRIPES, Enhanced School Services as Usual
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial 2023: Summer STRIPES Highlights & Side Effects. Trial Name: NCT04571320 — N/A
Summer STRIPES 2023 Treatment Timeline for Medical Study. Trial Name: NCT04571320 — N/A
~22 spots leftby Oct 2025